Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3)

John M Zajecka,1,2 Arielle D Stanford,3 Asli Memisoglu,4 William F Martin,5 Sanjeev Pathak3 1Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA; 2Psychiatric Medicine Associates, LLC, Skokie, IL, USA; 3Department of Clinical Research, Alkermes, Inc., Waltham, MA, USA; 4Depar...

Full description

Saved in:
Bibliographic Details
Main Authors: Zajecka JM, Stanford AD, Memisoglu A, Martin WF, Pathak S
Format: article
Language:EN
Published: Dove Medical Press 2019
Subjects:
buprenorphine
samidorphan
randomized clinical trial
major depressive disorder
adjunctive therapy
study design
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Online Access:https://doaj.org/article/fa8ef40e4dfd43178a91a5049d49e805
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/fa8ef40e4dfd43178a91a5049d49e805

Similar Items